Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Childhood acute lymphoblastic leukemia
Relapsed and refractory disease after frontline cure rates: blinatumomab, inotuzumab and CD19 CAR-T cells.
SITC Annual Meeting 2026
4–8 Nov 2026, Phoenix · Journal for ImmunoTherapy of Cancer 14 (Suppl 2 and 3), open access
1,109 regular and 19 late-breaking abstracts are in Crossref as open-access JITC supplement records (CC BY-NC); the supplement may still be filling in.
Indexed in Crossref
5 abstracts matching childhood acute lymphoblastic leukemia from the meeting's journal supplement, fetched live from Crossref 2026-11-12 10:42 UTC. This is a keyword search, not the complete abstract book.
- 179
- 384CD40 agonist and PD1 antagonistic antibody prolong survival and reprogram anti-tumor immunity in T call acute lymphoblastic leukemiaFaizah Alabi, Rakibul Islam, Pabitra Kumar Sardar, Todd A Triplett
- 383CD40 agonist and PD1 antagonistic antibody prolong survival and reprogram anti-tumor immunity in T cell acute lymphoblastic leukemia (T-ALL)Faizah Alabi, Rakibul Islam, Pabitra Kumar Sardar, Todd A Triplett
- 682Pharmacologic induction of B-cell maturation sensitizes B-cell precursor acute lymphoblastic leukemia to anti-CD20 immunotherapyMalgorzata Firczuk, Agnieszka Dabkowska, Martyna Janowska, Krzysztof Domka et al.
- 185Design and development of a fratricide-resistant allogenic CD7 CAR-T cell therapy with an RQR8 safety switch for the treatment of T-cell acute lymphoblastic leukemiaParidhi Gupta, Mario Prateek Selvam, Shraddha Banerjee, Swarnendu Bag et al.